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Abstract
Introduction Breast cancer is the most frequent malignant
disease in women. Exposure to estrogens throughout a
woman's life is a risk factor for the development of breast
cancer. Organochlorine compounds (OCCs), such as
pesticides and polychlorinated biphenyls, are persistent
lipophilic chemicals identified as endocrine disruptors, mainly
with estrogenic effects. To test the hypothesis that the amount
and quality of organochlorine residues in adipose tissue
adjacent to breast carcinoma affect the biological behavior of
the tumor, we studied biomarker expression in breast carcinoma
and the OCC body burden in patients from an urban area
adjacent to Paraná fluvial system, Argentina.
Methods The studied patients were 55 women who had
undergone excision biopsies of a breast lesion diagnosed as
invasive breast carcinoma. Analysis of OCC residues in breast
adipose tissue was conducted by electron-capture gas–liquid
chromatography. Estrogen receptor alpha (ERα), progesterone
receptor (PR) and proliferative activity (Ki-67) levels were
measured in paraffin-embedded biopsies of breast tumors by
immunohistochemistry.
Results All patients had high levels of organochlorine pesticides
in their breast adipose tissue. The most frequently detected
compounds were p,p'-dichlorodiphenyldichloroethylene,
hexachlorobenzene and β-hexachlorocyclohexane. When the
whole sample was analyzed, no correlation between ERα or PR
expression and OCC levels were found. In the subgroup of ERα-
positive breast carcinoma patients, however, there was a
positive correlation between PR expression (an estrogen-
induced protein) in the neoplastic cells and OCC levels in
adipose tissue surrounding the tumor. More significantly, all the
ERα-positive breast carcinomas from postmenopausal women
exhibited high proliferation when organochlorine levels in the
surrounding adipose tissue reached levels higher than 2600
ppb. No associations were found between the organochlorine
body burden and any other marker of tumor aggressiveness,
such as node involvement or tumor size.
Conclusion The present results support the hypothesis that
organochlorine residues in adipose tissue adjacent to breast
carcinoma generate an estrogenic microenvironment that may
influence the biological behavior of the tumor through ERα
activation and ERα-dependent proliferation. These findings may
have therapeutic implications, since interference between
organochlorine compounds and hormonal therapy could be
expected to occur.
Introduction
Breast cancer is the most frequent malignant disease in
women. Exposure to estrogens throughout a woman's life,
including the period of intrauterine development, is a risk fac-
tor for the development of breast cancer [1-3]. Epidemiologi-
cal studies suggest a strong correlation between estrogen
and/or xenoestrogen exposure and cancer, which is sup-
ported by numerous in vivo and in vitro experimental studies
DDE = dichlorodiphenyldichloroethylene; DDT = dichlorodiphenyltrichloroethane; ERα = estrogen receptor alpha; GC = gas chromatography; OCC 
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that attest to the proliferative and carcinogenic potency of
estrogens [4].
Organochlorines present in the environment include agricul-
tural pesticides and industrial compounds. Chemically stable
and strongly lipophilic, organochlorine compounds (OCCs)
have slow degradation rates and tend to bioaccumulate in
lipid-rich tissues. Because some OCCs act as estrogen ago-
nists they have been linked to an increased incidence of breast
cancer [5,6], although not all data have been consistent [7-9].
People are exposed to OCCs from the environment and from
residues in food. We recently reported that women from Santa
Fe City area, a littoral region in Argentina, had high levels of
organochlorine pesticides in their breast adipose tissue, and,
more significantly, p,p'-dichlorodiphenyldichloroethylene (p,p'-
DDE) was present in all sampled women and at high concen-
trations. The diet was a major factor that influenced the orga-
nochlorine pesticide body burden. Fish, particularly fatty
varieties caught in local rivers, as well as other fat-rich meats
were significant sources of exposure [10].
It is of interest, alongside designing studies to establish a link
between xenoestrogens and breast cancer risk, to determine
whether or not changes in the tumor microenvironment, due to
organochlorine accumulation and release, affect the biological
behavior of the tumor. In a nested case–control study, it has
recently been demonstrated that patients with increased num-
bers of epithelial cells expressing estrogen receptor alpha
(ERα) in normal lobular units are at increased risk of subse-
quent invasive breast cancer [11]. These results suggest that
overexpression of estrogen receptor in benign breast epithe-
lium may increase estrogen sensitivity, thereby creating a per-
missive state that can lead to malignancy. As ERα mediates
mammary cell differentiation and function, inappropriate expo-
sure of cells to estrogens or xenoestrogens might alter the
behavior of an established neoplasia. This might have thera-
peutic implications [12]. Contradictory results have been
reported in studies that addressed the possible relationship
between organochlorine levels, breast cancer aggressiveness
and prognosis [13-16]. These differences may be due to
methodological approaches since organochlorine levels were
measured in different physiological compartments (adipose
tissue and serum samples), which results in inappropriate
comparisons [17,18].
We hypothesized that the amount and quality of the organo-
chlorine residues in adipose tissue adjacent to breast carci-
noma might affect the biological behavior of the tumor. To test
this hypothesis we conducted a cross-sectional study evaluat-
ing whether or not the amount and/or quality of organochlorine
residues adjacent to breast carcinomas are associated with
the expression of biological markers (paying special attention
to hormone-dependent and hormone-independent breast can-
cer markers). We studied a population of women with breast
lesions who reside in Santa Fe City and nearby locations, an
urban area on the coast of Paraná River in a region that is char-
acterized by intensive agricultural activities. This agricultural
activity favors an elevated prevalence of environmental expo-
sures, which our laboratory has recently confirmed [10].
Materials and methods
Study subjects
Participants included in this report were a subsample of sub-
jects who were enrolled in a study to assess the OCC body
burden among residents of Santa Fe City area in Argentina
[10]. This subsample (n = 55) comprised women that under-
went an excision biopsy of a breast lesion diagnosed as inva-
sive breast carcinoma between March 1998 and April 1999 in
regional hospitals of Santa Fe City. All patients were urban
residents at the time of surgery, were nonoccupationally
exposed to persistent OCCs and were subjected to no thera-
peutic intervention before biopsy. An informed consent form
was signed by all participants, 49 of whom completed a ques-
tionnaire.
The questionnaire provided information about sociodemo-
graphic factors, menopausal status, weight loss, height, parity,
breast-feeding, dietary habits and hormone replacement ther-
apy. Since OCC residue removal during lipolysis could be
expected, periods of breast-feeding and weight loss before
surgery were included in the questionnaire. The interview was
conducted by a trained social worker by telephone and/or
home visit. Histopathological reports and medical records
were available for all patients. The primary tumor extent (T1–
T4) and lymph node status were determined using the Ameri-
can Joint Committee on Cancer criteria [19]. Approval for this
study was obtained from the Universidad Nacional del Litoral
Institutional Review Board (Santa Fe, Argentina).
Tissue sample collection
At the time of biopsy 0.5–1.0 g breast adipose tissue adjacent
to the lesion was collected and weighed, was frozen at -70°C
and was stored until organochlorine analysis. Paraffin blocks
of breast tumor samples, previously fixed in 10% buffered for-
malin for 24 hours at room temperature, were available for
immunohistochemical evaluation of tumor biomarkers.
Laboratory assays
Detection of organochlorine in adipose tissue
Breast adipose tissue was analyzed for the presence of the fol-
lowing compounds: hexachlorobenzene, hexachlorocyclohex-
ane isomers (α-hexachlorocyclohexane,  β-
hexachlorocyclohexane and lindane), aldrin, oxychlordane, α-
chlordane, γ-chlordane, heptachlor, heptachlor epoxide, diel-
drin, endrin, mirex, metoxychlor, DDE (p,p'-DDE and o,p'-DDE),
tetrachlorodiphenylethane (p,p'-tetrachlorodiphenylethane,
o,p'-tetrachlorodiphenylethane), dichlorodiphenyltrichlo-
roethane(p,p'-DDT, o,p'-DDT) and eight polychlorinated biphe-
nyl congeners (International Union of Pure and AppliedAvailable online http://breast-cancer-research.com/content/8/4/R47
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Chemistry numbers 077, 118, 128, 138, 170, 180, 187 and
195).
Concentrations of organochlorines were measured following
the method previously described by Muñoz-de-Toro and col-
leagues [10]. Briefly, an aliquot of 500 mg adipose tissue was
dehydrated and then extracted in acetone–petroleum ether
(25:75, v/v). The extract was filtered and the container rinsed
with petroleum ether. All the petroleum ether fractions were
collected and evaporated to dryness, and the percentage of
fat in each tissue sample was calculated. Then, an aliquot of
200 mg fat from each sample was dissolved in 5 ml petroleum
ether. Solid-phase extraction cleanup was performed using
Supelclean LC-Alumina-N SPE tubes (Supelco, Bellefonte,
PA, USA), and a second cleanup was performed using Supel-
clean Envi-Florisil SPE tubes (Supelco). Ten milliliters of
ethylic ether–petroleum ether (15:85, v/v) was used to elute
the chlorinated compounds from the microcartridge.
A gas–liquid chromatograph (Varian™ model 3400, Varian
Inc., Palo Alto, CA, USA) equipped with a 63Ni electron-cap-
ture detector was used for the analysis of residues. The gas
chromatography (GC) columns used were: a Megabore Cap-
illary GC Column DB 608 (30 m × 0.53 mm ID, film thickness
0.83 μm; J&W Scientific, Taejon, Korea), a GC Capillary Col-
umn CP-Sil 8 CB (50 m × 0.25 mm ID, film thickness 0.12 μm;
VWR International B.V., Amsterdam, The Netherlands), and a
GC packed column (2 m × 2 mm) coated with 1.5% SP 2250
+ 1.95% SP 2401 on a Supelcoport 100–120 ID mesh (VWR
International B.V., West Chester, PA, USA).
Organochlorine pesticide standards Pestanal (Honeywell
Riedel-de Haën Fine Chemicals, Seelze, Germany) and poly-
chlorinated biphenyl congener standards (Ultra Scientific,
North Kingstown, RI, USA) were used. All the solvents used
were of pesticide-grade quality (Merck, Darmstadt, Germany).
The OCC presence and level were confirmed using a GC–
mass spectrometry system (VG Trio 2; VG Analytical, Man-
chester, UK) in randomly selected samples. The operational
quality control and limits of detection have been reported pre-
viously [10].
Tumor biomarkers
ERα expression, progesterone receptor (PR) expression and
Ki-67 expression were measured by immunohistochemistry as
previously described [20]. Samples received microwave pre-
treatment for antigen retrieval. Primary antibodies used were
ERα (clone 6F-11) and PR (clone 1A6) from Novocastra Lab-
oratories (Newcastle upon Tyne, UK) and Ki-67 (clone MIB-1;
Amac, Westbrook, ME, USA), diluted 1:60, 1:20 and 1:100,
respectively. Incubation with primary antibody was performed
at 4°C for between 14 and 16 hours. Biotinylated anti-mouse
IgG (Sigma, St Louis, MO, USA) was used as a second anti-
body; biotin was detected with the streptavidin–peroxidase
(Sigma) complex. Diaminobenzidine tetrahydrochloride
(Sigma) was used as a chromogen.
Biomarker expression was measured in the epithelial compart-
ment. A proliferation index was obtained by considering the
percentage of all Ki-67-positive cells independently of staining
intensity (2,000 cells were counted/tissue section and at least
three sections per sample were included). The Ki-67 assay
(MIB-1) values were categorized according to Trihia and col-
leagues [21] as follows: low proliferation, ≤ 9.5%; intermedi-
ate proliferation, >9.5 and ≤ 15.5%; and high proliferation,
>15.5%. ERα and PR were quantified by considering the per-
centage of positive cells, and the results were categorized into
three groups [22]: negative, 0%; weakly positive, >0 and
<10%; and strongly positive, ≥ 10%.
Data analysis
The variables evaluated were organochlorine concentrations,
age at biopsy (years), menopause status at biopsy (pre/post),
age at menopause (years), years between menopause and
surgery, years lived in a rural area, occurrence of weight loss
(>3 kg) during the year before biopsy (yes/no), body mass
index (kg/m2), number of children, months of lactation (aver-
aged when several lactations and categorized into three
groups: less than 3 months; from 3 to 6 months; and more
than 6 months), animal fat intake (categorized into two groups:
low, patients who ate lean red meat and processed meat (sau-
sage, salami, etc.) infrequently; and high, those who ate red
meat and processed meat regularly), freshwater fish intake
(less than once a week, or at least once a week), and dairy
product intake (low, infrequent; intermediate, once a week; or
high, every day). Each food type was evaluated individually and
then all food types were evaluated together as a score summa-
tion.
In addition, the variables tumor size (categorized as T1, 0–2
cm; 2 < T2 < 5 cm; T3, ≥ 5 cm; and T4, any size that invades
muscle or skin), lymph node metastasis (none or present), and
ERα, PR and MIB-1 expression (percentages and categories,
described earlier) were evaluated. Expressions of ERα and PR
were also dichotomized as positive and negative to conduct
stratified analysis.
Nondetectable levels of OCCs were estimated as the mean
between 0 and the detection limit. The OCC values were log-
transformed when parametric tests were used. The central
tendency of organochlorine residues was reported as geomet-
ric means.
All possible pairs of variables were tested for associations by
appropriate statistical tests. Parametric tests were used when
the assumptions were completely met, and nonparametric
tests were used when assumptions were not met (Mann–
Whitney tests to compare two groups, Kruskal–Wallis tests to
compare three or more groups of a nominal variable, Jonck-Breast Cancer Research    Vol 8 No 4    Muñoz-de-Toro et al.
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heere–Terpstra tests to compare three or more groups of an
ordinal variable, and Spearman's Rho correlation to compare
two continuous variables). Pearson and Mantel–Haenszel chi-
square tests and Fisher's exact tests were used to compare
proportions.
Results are reported for the pairs that were of interest (i.e.
organochlorine residues and tumor biomarker expression),
whereas the other pairs were used to assess the probability
that an association of interest was caused by confounding or
interaction effects of a third variable. Although multivariable
analysis was not possible due to the limited sample size, strat-
ification was conducted every time it was of interest to assess
the associations within values of a third variable.
Results
Patient and tumor characteristics
Table 1 presents summary descriptive information on the
study subjects. All tumors were classified as invasive carcino-
mas, and the tumor size varied widely (T1 = 30.2%, T2 =
52.8%, T3 = 5.7%, and T4 = 11.3% of our breast carcinoma
patients). Node-positive patients (one or more axillary lymph
nodes with neoplastic cells) comprised 46.9% of participants.
Data on tumor biomarker expression are summarized in Table
2. According to hormone receptor expression, 50.0% of carci-
nomas appeared to be hormone-dependent tumors (ERα-pos-
itive and PR-positive) and 30.8% were hormone-independent
tumors (ERα-negative and PR-negative). Breast carcinomas
from premenopausal patients showed a lower percentage of
Table 1
Characteristics of patients studied
Continuous variables
Age (years) 60.5 ± 11. 6 (n = 51)
Body mass index (kg/m2) 25.4 ± 4.8 (n = 46)
Number of full-term pregnancies 2.2 ± 1.9 (n = 48)
Rural residence (years) 10.4 ± 17.8 (n = 45)
Categorical variables
Breastfeeding (n = 45)
<3 months total 35.6
>3 and <6 months total 11.1
>6 months total 53.3
Menopausal status (n = 49)
Premenopausal 24.5
Postmenopausal 75.5
Weight loss (>3 kg) during the year before biopsy (n = 42)
No 76.2
Yes 23.8
Freshwater fish consumption (n = 47)
Less than once a week 68.1
At least once a week 31.9
Dairy product intake (n = 46)
Infrequent 6.5
At least once a week 17.4
Every day 76.1
Animal fat intake (n = 46)
Low 34.8
High 65.2
Continuous variables presented as the mean ± standard deviation; categorical variables presented as the percentage.Available online http://breast-cancer-research.com/content/8/4/R47
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ERα-positive cells (12.2 ± 19%) than those from postmeno-
pausal patients (42.3 ± 35.5%; Mann–Whitney test, P =
0.021). ERα expression in breast tumors from node-positive
patients (23.3 ± 32.4%) appeared to be lower than in tumors
from node-negative women (43.6 ± 34.2%), but this differ-
ence was not statistically significant (Mann–Whitney test, P =
0.065). PR-negative breast carcinomas showed a higher pro-
liferative index (33.4 ± 15.7%) than PR-positive carcinomas
(22.0 ± 11.5%; Mann–Whitney test, P = 0.015).
There was a positive association between animal fat intake
and tumor proliferative index (Fisher's exact test, P = 0.025):
69.7% of tumors with high proliferation were from patients
with high fat consumptions. On the other hand, dairy product
intake was positively correlated with ERα expression in carci-
nomas: 0%, 23.8% and 42.1% for low consumption, interme-
diate consumption and high consumption, respectively
(Jonckheere–Terpstra test, P = 0.017).
Organochlorine levels in breast adipose tissue
A considerable high frequency of occurrence of organochlo-
rine residues and elevated concentrations of organochlorine
residues were found in breast adipose tissue of all participants
(n = 55) (Table 3). The residues found most frequently were
p,p'-DDE in all patients analyzed, hexachlorobenzene in
87.3%, β-hexachlorocyclohexane in 74.5%, heptachlor epox-
ide in 36.4%, oxychlordane in 32.7%, and heptachlor in
21.8%. p,p'-DDT was detected in three patients (5.5%). The
concentrations of organochlorine residues in breast adipose
tissue were very high, with maximum values of 4794 ppb for
p,p'-DDE and 1780 ppb for β-hexachlorocyclohexane.
Organochlorine levels and characteristics of the 
adjacent tumors
Analysis of all subjects found no associations between the
organochlorine body burden and any marker of tumor aggres-
siveness such as node involvement, tumor size or proliferative
activity. Moreover, the 12 patients who died within 4 years fol-
lowing surgery had organochlorine levels that did not differ
from those of the surviving studied subjects (Mann–Whitney
test, P = 0.303).
Regarding levels of organochlorine and the expression of
biomarkers in adjacent breast tumors, concentrations of orga-
nochlorine appeared higher when surrounding hormone-
dependent (ERα-positive and PR-positive) tumors (geometric
means for total organochlorines in hormone-dependent
tumors = 1169.2 ng/g versus hormone-independent tumors =
711.1 ng/g); however, this trend was not statistically signifi-
cant (Mann–Whitney test, P = 0.379). Interestingly, in the sub-
group of ERα-positive tumors, a significant positive correlation
was observed between PR expression and total organochlo-
rine levels (Spearman's Rho correlation, P = 0.044) (Figure 1),
mainly due to p,p'-DDE levels since the strongest correlation
was observed between PR expression and p,p'-DDE (Spear-
man's Rho correlation, P = 0.010).
The estrogenic effect of OCCs was also evident when tumor
proliferative activity was evaluated in ERα-positive breast
tumors from postmenopausal women. As shown in the sub-
group of ERα-positive breast tumors from postmenopausal
patients (Figure 2), all the adjacent tumors had high cellular
proliferation when levels of OCC residues were 2600 ppb or
higher (above the dashed line) (Fisher exact test, P = 0.017 –
statistical analyses of tumors with low and intermediate prolif-
eration were grouped). Furthermore, it is interesting to note the
bimodal distribution of the OCC concentrations in the group
of highly proliferative ERα-positive breast carcinomas from
postmenopausal patients (Figure 2). The subgroup clustered
above the 2600 ppb threshold were patients that had been
menopausal for a long time (mean 31 years), while those with
low total OCCs (<2600 ppb) and high proliferation had been
in menopause for a shorter time (mean 17 years; Mann–Whit-
ney test, P = 0.032). Moreover, when ERα-positive tumors
Table 2
Biomarkers of hormone dependence and proliferative activity in breast carcinomas
Immunophenotypea Percentage of cases (n)
Hormone dependence
ERα-positive/PR-positive 50.0 (26)
ERα-positive/PR-negative 11.5 (6)
ERα-negative/PR-positive 7.7 (4)
ERα-negative/PR-negative 30.8 (16)
MIB-1 category
Low proliferation 12.8 (6)
Intermediate proliferation 17.0 (8)
High proliferation 70.2 (33)
aCriteria adopted to establish cut-off values are described in Materials and methods. ERα, estrogen receptor alpha; PR, progesterone receptor.Breast Cancer Research    Vol 8 No 4    Muñoz-de-Toro et al.
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from premenopausal patients were analyzed, all tumors with
high proliferation had low total OCC levels (data not shown).
In other words, patients that had been menopausal for a long
time exhibited high proliferation if OCC levels surrounding the
tumor were high, whereas highly proliferative ERα-positive
breast carcinomas with a microenvironment of low OCC levels
were seen either in premenopausal women or in women that
went through menopause more recently.
Discussion
This study presents evidence regarding an estrogenic effect of
OCCs on human mammary tumors that developed in a rich
OCC environment. The PR expression in ERα-positive breast
carcinomas was positively associated with OCC concentra-
tion in the adjacent adipose tissue, while in the subgroup of
postmenopausal women, when low serum levels of endog-
enous estrogen are expected, high levels of OCCs in the adi-
pose tissue surrounding breast tumor were associated with
high proliferative activity. The present results support the
hypothesis that organochlorine residues in adipose tissue
adjacent to breast carcinoma generate an estrogenic microen-
vironment that may influence the biological behavior of the
tumor.
We recently demonstrated that women living in an urban area
of an agricultural and industrial region of Argentina had high
levels of organochlorine residues in their breast adipose tissue
[10]. More significantly, p,p'-DDE was present in all subjects
at high concentrations. In the present report, the study sub-
jects were a subsample of women from our previous work [10]
who were diagnosed with invasive breast carcinoma. As
expected, these women also exhibited high levels of organo-
chlorine residues in the adipose tissue adjacent to the breast
tumors.
Epidemiologic studies have identified numerous prognostic
parameters in breast cancer patients. Among these parame-
ters, tumor size, cell proliferation, lymph node involvement and
steroid receptor status are accepted as the most significant
[23]. Even though our sample size is small, our results agree
with randomized clinical studies performed to provide prog-
nostic information in patients with breast carcinoma [23]. We
have found that premenopausal and node-positive women
showed a lower expression of ERα in their tumors, and that
PR-negative carcinomas have a higher proliferative index.
These observations agree with large well-designed clinical
studies [23] and attest to the representativeness of our sam-
ple.
The relation of diet, especially fat intake, to recognized breast
cancer prognostic indicators was investigated in humans as
well in animal models. In rats, a high-fat diet significantly stim-
ulated tumor proliferation and cell kinetics in chemically
induced mammary carcinomas [24], while in women an
increase in saturated fat intake was positively associated with
tumor growth and/or spread [25]. Consistent with this, our
tumors from patients that reported high fat consumption exhib-
ited high proliferative indices. In the present study, dairy prod-
uct intake was positively correlated with tumor ERα
expression. This result suggests that these dietary compo-
nents could modify the tumor biological behavior, improving
the response to endocrine therapy and/or survival in breast
carcinoma patients.
Figure 2
High organochlorine levels promote high proliferation in estrogen  receptor-α positive breast carcinomas of postmenopausal High organochlorine levels promote high proliferation in estrogen 
receptor-α positive breast carcinomas of postmenopausal. All 
ERα-positive breast carcinomas from postmenopausal women had high 
cellular proliferation when levels of organochlorine residues were 2600 
ppb or higher (above the dashed line) (Fisher's exact test, P = 0.017 – 
statistical analysis of tumors with low and intermediate proliferation 
grouped).
Figure 1
Organochlorine levels modulate progesterone receptor expression in  estrogen receptor-α positive breast carcinomas Organochlorine levels modulate progesterone receptor expres-
sion in estrogen receptor-α positive breast carcinomas. The per-
centage of PR expression in ERα-positive breast carcinoma was 
positively correlated with organochlorine levels in the adjacent adipose 
tissue (Spearman's Rho test, P = 0.044).Available online http://breast-cancer-research.com/content/8/4/R47
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Previous studies on estrogenic organochlorine levels and
breast cancer have focused mainly on risk assessment while
few of them have taken into account hormone receptor status
and/or biomarkers of tumor aggressiveness. Dewailly and col-
leagues [26] and Liljegren and colleagues [27] found that
patients with ERα-positive tumors had higher DDE and a
higher polychlorinated biphenyl body burden than controls,
but Muscat and colleagues [16] failed to confirm this finding.
In the present study, a trend of higher concentrations of total
organochlorines surrounding hormone-dependent (ERα-posi-
tive and PR-positive) tumors was apparent; this trend was not
statistically significant, possibly due to the small sample size.
Most organochlorine pesticides found in our samples were
defined as xenoestrogens [28]; consistent with this, a positive
association was established in the ERα-positive breast tumor
subgroup between PR expression and OCC levels in adjacent
adipose tissue. This result suggests an upregulation of PR
expression via an ERα-dependent mechanism.
DDT isomers and metabolites bind to and transcriptionally
activate human ERα [29]. Moreover, organochlorine has been
shown estrogenic in MCF-7 cells by the expression of PR [29].
Using a transgenic mouse model, Villa and colleagues [30]
showed that PR mRNA was significantly induced by DDT iso-
mers in tissues positive for estrogen receptors, and that the
estrogenic action of p,p'-DDE was more efficient in organs that
expressed ERβ, such as the mammary gland. Organochlorines
might induce the observed changes in PR expression either
directly by binding ERs or indirectly by increasing sensitivity to
endogenous estrogens, or affecting the amount and type of
estrogen metabolites with estrogenic properties. The local
estrogen synthesis in neoplastic breast tissue depends on two
principal pathways: the 'aromatase pathway', which trans-
forms androgens into estrogens; and the 'sulfatase pathway',
which converts estrone sulfate into estrone [31,32]. It is
tempting to suggest that OCC could increase the local bio-
synthesis of estrogens through the modulation of the afore-
mentioned enzymatic pathways.
Regarding the organochlorine body burden and the prognosis
of breast carcinoma patients, adverse effects have been sug-
gested by Demers and colleagues [13], Hoyer and colleagues
[14] and Muscat and colleagues [16]. In the present study, the
markers of aggressiveness such as tumor size or node involve-
ment show no associations with the organochlorine body bur-
den, while the proliferative activity was associated with OCC
levels when low endogenous estrogen serum levels are
expected (postmenopause). An elevated cellular proliferation
in breast carcinoma patients that have been menopausal for a
long time depended on the levels of OCCs, whereas high cel-
lular proliferation in those premenopausal patients or those
that had more recently gone through menopause appeared to
be independent of OCC concentrations. Our result agrees
with results recently obtained in vitro, where proliferation of
MCF-7 was induced by xenoestrogens when tumor cells were
cultured in a medium devoid of estrogen [33]. Our study has
the characteristic that breast tumors in our series were diag-
nosed later than in developed countries, where active breast
cancer screening programs work properly. Based on this
observation, it is suggested that tumors in our series devel-
oped and progressed in an organochlorine-rich environment;
following their natural history without intervention, thus provid-
ing more accurate information regarding the OCC effect on
breast tumor biological behavior.
Table 3
Concentrations of organochlorine residues in breast adipose tissue adjacent to a malignant lesion
Compound Frequency (%) Geometric mean (95% 
confidence interval)
Range (ppb)
p,p'-Dichlorodiphenyldichloroethylene 100 541.9 (398.3–737.3) 20–4,794
Hexachlorobenzene 87.3 33.9 (22.2–51.6) BDL-252
β-Hexachlorocyclohexane 74.5 81.7 (43.1–154.8) BDL-1,780
Heptachlor epoxide 36.4 5.5 (3.8–7.9) BDL-222.0
Oxychlordane 32.7 6.5 (4.0–10.5) BDL-622.0
Heptachlor 21.8 2.8 (2.3–3.4) BDL-24
p,p'-Dichlorodiphenyltrichloroethane 5.5 2.5 (1.9–3.1) BDL-159
o,p'-Dichlorodiphenyldichloroethylene 1.8 2.2 (1.8–2.6) BDL-255
Dieldrin 1.8 2.1 (1.9–2.3) BDL-34
Total polychlorinated biphenyls 1.8 2.1 (1.9–2.4) BDL-81
Total organochlorines 100 885.3 (646.6–1,212.1) 20.0–5,861
BDL, below detection limit.Breast Cancer Research    Vol 8 No 4    Muñoz-de-Toro et al.
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The present results highlight the importance of differentiating
between tumor types, in terms of the estrogen receptor status
and PR status, when analyzing the effects of both estrogens
and xenoestrogens. The emerging picture is that epithelium
and stromal compartments interact via a complex network of
diffusible factors, resulting in the modulation of cell growth and
differentiation, which facilitates tumor development and/or
progression in a permissive, xenoestrogen-rich microenviron-
ment. It is not known how the induction of cell proliferation and
the increased expression of PR in tumors developed in an
organochlorine-rich microenvironment would affect disease-
related survival, as hormone-receptor-positive tumors may be
associated with a more favorable prognosis compared with
hormone-receptor-negative tumors [34].
In summary, the present results support the hypothesis that
the amount and quality of the organochlorine residues in adi-
pose tissue adjacent to breast carcinoma is responsible for
generating an estrogenic microenvironment that may influence
the tumor biological behavior. In the ERα-positive breast car-
cinoma, organochlorine levels in adipose tissue were associ-
ated with an increase in PR expression and cell proliferation,
both mechanisms induced through estrogen action and ERα
activation. While several in vitro works have shown the
xenoestrogen effect on breast tumor cell lines [28,29,33],
present results suggest the occurrence of in vivo estrogenic
effects of organochlorine residues on human breast tumors.
Also, the results suggest that tumors of women at advanced
menopause depend upon a microenvironment of high xenoes-
trogen levels to induce high cell proliferation. New studies with
larger samples would be necessary to confirm this preliminary
result.
Conclusion
The present results support the hypothesis that organochlo-
rine residues in adipose tissue adjacent to breast carcinoma
generate an estrogenic microenvironment that may influence
the biological behavior of the tumor through ERα activation
and ERα-dependent proliferation. These findings may have
therapeutic implications, since interference between organo-
chlorine compounds and hormonal therapy could be expected
to occur.
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